Cirrhosis of the liver
215 results
1 - 100
Colchicine for alcoholic and non‐alcoholic liver fibrosis and cirrhosis- Albumin for people with liver cirrhosis and bacterial infections
- Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease
- Treatment for ascites in adults with decompensated liver cirrhosis: a network meta‐analysis
- Model for end stage liver disease for prediction of mortality in people with cirrhosis
- Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis
- Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease
- Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta‐analysis
- Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in people with liver cirrhosis: a network meta‐analysis
- Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta‐analysis
- Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta‐analysis
- Expanded polytetrafluoroethylene (ePTFE)‐covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis
- Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta‐analysis
- Bezafibrate for primary biliary cirrhosis
- Methotrexate for primary biliary cirrhosis
- Colchicine for primary biliary cirrhosis
- Ursodeoxycholic acid for primary biliary cirrhosis
- D‐penicillamine for primary biliary cirrhosis
- Glucocorticosteroids for primary biliary cirrhosis
- Hormone replacement for osteoporosis in women with primary biliary cirrhosis: Cochrane systematic review
- Bisphosphonates for osteoporosis in primary biliary cirrhosis: Cochrane systematic review
- Cyclosporin A for primary biliary cirrhosis
- Physical exercise for people with cirrhosis
- Liver and spleen stiffness as assessed by vibration controlled transient elastography for diagnosing clinically significant portal hypertension in comparison with other elastography‐based techniques in adults with chronic liver disease
- Fibrin‐based haemostatic agents for reducing blood loss in adult liver resection
- Platelet count, spleen length, and platelet count‐to‐spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
- Somatostatin analogues for acute bleeding oesophageal varices
- Antioxidant supplements for liver diseases: Cochrane systematic review
- Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis
- Pharmacological interventions for non‐alcohol related fatty liver disease (NAFLD)
- Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
- Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis: Cochrane systematic review
- Bile acids for liver‐transplanted patients
- Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
- Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis
- Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome
- Chlorambucil for patients with primary biliary cirrhosis: Cochrane systematic review
- Glucocorticosteroids for primary sclerosing cholangitis: Cochrane systematic review
- Anabolic‐androgenic steroids for alcoholic liver disease
- Branched‐chain amino acids for people with hepatic encephalopathy
- Azathioprine for primary biliary cirrhosis
- Carvedilol versus traditional, non‐selective beta‐blockers for adults with cirrhosis and gastroesophageal varices
- Terlipressin for acute esophageal variceal hemorrhage
- Nutritional supplementation for nonalcohol‐related fatty liver disease: a network meta‐analysis
- Liver fibrosis stage based on the four factors (FIB‐4) score or Forns index in adults with chronic hepatitis C
- Lifestyle modifications for nonalcohol‐related fatty liver disease: a network meta‐analysis
- Medicinal herbs for hepatitis C virus infection
- L‐ornithine L‐aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis
- Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding
- Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices
- Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease)
- Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases
- Pharmacological interventions for primary biliary cholangitis
- Ribavirin monotherapy for chronic hepatitis C